Nate Pennell, MD, PhD

Emrullah Yilmaz, MD, PhD

Co-Investigator

Wen Ma

Co-Investigator

Cleveland Clinic Taussig Cancer Institute

Multiple Cancer Types

Impact Grant

Cancer Universal Consent, Biorepository and NGS Sequencing

Providing the best care requires us to focus on in individual characteristics and needs of each unique patient with cancer. To create the most informed plan of care we will perform Next Generation Sequencing to have the full genomic profile of each patient. In addition, we will drive future innovation by create a universal consent and biorepository process.